Massar Capital Management LP Invests $381,000 in Addus HomeCare Co. (NASDAQ:ADUS)

Massar Capital Management LP bought a new stake in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 3,040 shares of the company's stock, valued at approximately $381,000.

Other large investors have also recently bought and sold shares of the company. IHT Wealth Management LLC boosted its holdings in Addus HomeCare by 51.5% during the fourth quarter. IHT Wealth Management LLC now owns 4,402 shares of the company's stock worth $552,000 after purchasing an additional 1,496 shares during the last quarter. Stifel Financial Corp lifted its position in Addus HomeCare by 1.2% during the 4th quarter. Stifel Financial Corp now owns 12,794 shares of the company's stock worth $1,604,000 after buying an additional 153 shares in the last quarter. MetLife Investment Management LLC boosted its stake in shares of Addus HomeCare by 7.0% during the 4th quarter. MetLife Investment Management LLC now owns 10,626 shares of the company's stock worth $1,332,000 after buying an additional 692 shares during the last quarter. Natixis increased its position in shares of Addus HomeCare by 111.9% in the fourth quarter. Natixis now owns 250 shares of the company's stock valued at $31,000 after acquiring an additional 132 shares during the last quarter. Finally, Capital Research Global Investors acquired a new stake in shares of Addus HomeCare in the fourth quarter valued at about $51,149,000. Institutional investors and hedge funds own 95.35% of the company's stock.

Analyst Upgrades and Downgrades

ADUS has been the topic of several recent analyst reports. JMP Securities reaffirmed a "market outperform" rating and set a $150.00 price target on shares of Addus HomeCare in a research report on Tuesday. StockNews.com downgraded shares of Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. Macquarie reissued an "outperform" rating and issued a $129.00 price objective on shares of Addus HomeCare in a research report on Thursday, February 27th. Oppenheimer upped their target price on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a report on Friday, January 24th. Finally, Stephens reiterated an "overweight" rating and set a $142.00 price target on shares of Addus HomeCare in a report on Wednesday, March 12th. One investment analyst has rated the stock with a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of "Buy" and an average target price of $139.00.

Addus HomeCare Stock Up 1.0 %

Shares of Addus HomeCare stock traded up $1.04 on Friday, hitting $100.58. The stock had a trading volume of 97,408 shares, compared to its average volume of 162,977. The stock has a market cap of $1.83 billion, a price-to-earnings ratio of 23.02, a price-to-earnings-growth ratio of 1.41 and a beta of 0.93. The business's 50 day moving average is $97.93 and its two-hundred day moving average is $116.15. Addus HomeCare Co. has a twelve month low of $88.96 and a twelve month high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings data on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). The firm had revenue of $297.14 million during the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. As a group, equities analysts predict that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.